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Flow-cytometryInfection with Cytomegalovirus is associatedwith accelerated immunosenescence. Expansions of CMV-speciﬁc T
cell responses have previously been demonstrated to affect the ability of T cells to respond to other infections.
Most people above 60 years of age displayM. tuberculosis-speciﬁc immunity because of vaccination, exposure,
or both. T-cell responses can be assessed by measuring intracellular IFN-γ in vitro after tuberculin stimulation.
Here we investigated tuberculin-speciﬁc CD4 T-cell responses in independently living healthy older people in
the South of England using ﬂow-cytometry. Individuals were investigated for tuberculin and CMV-speciﬁc T-
cell immunity using in vitro antigen stimulation followed by intracellular staining for IFN-γ, TNF-α, IL2, as well
as degranulation and CD154 upregulation. We also examined a control group of younger individuals (20–
35 years of age). There was no signiﬁcant difference between older and young people in regards to tuberculin
responsiveness of CD4 T-cells; however, older people seemed to show more outliers. Increased responsiveness
to tuberculin was signiﬁcantly correlated to CMV responsiveness but not age. In older donors, the memory
phenotype of tuberculin-induced T-cells was signiﬁcantly skewed towards a more terminal differentiation
phenotype in CMV-infected compared to uninfected individuals and the degree of skewing correlated
quantitativelywith the size of the CMV-speciﬁc CD4 T-cell response. This is a fundamental advance over previous
reports of changes of the tuberculin-speciﬁc CD4 T-cell responsewith CMV serostatus. Our results show that how
the immune system responds to CMV has a fundamental impact on the phenotype and function of the immune
response to mycobacterial antigens in older life.
© 2014 Elsevier Inc. All rights reserved.1. Introduction
Human Cytomegalovirus (HCMV) is the largest known herpes virus
and infects up to 90% of the population worldwide. Although CMV
establishes latent infections, which are asymptomatic in the immuno-
competent host, the impact of CMV on the memory T cell compartment
is substantial. CMV infection results in an accumulation of late differen-
tiated T cells and an increased ratio of memory over naive T cells, with
approximately 10% of total T cell responses dedicated to CMV antigensst [grant number R107/0209].
cal School, MRB, Biology Road,
71; fax: +44 1273 877834.
ghts reserved.in seropositive people. (Almanzar et al., 2005; Chidrawar et al., 2009;
Derhovanessian et al., 2011; Looney et al., 1999; Sylwester et al., 2005).
During ageing, both CD4 and CD8 naive T cells signiﬁcantly decline
in seropositive individuals (Chidrawar et al., 2009; Fagnoni et al.,
2000; Moro-Garcia et al., 2012). Since the number of naive T cells is
central to immune efﬁcacy, CMV infection has been associated with
premature T cell response decline (or immunosenescence) and reduced
ability of the host to mount effective immune responses against other
infections or vaccination.
Age-driven changes in T cell immunity associated with CMV
infection have been linked to an increased risk of serious complications
of inﬂuenza in elderly people (Moro-Garcia et al., 2012), in particular
because CMV seropositive older people have reduced ability to mount
effective cellular and antibody responses to inﬂuenza vaccination. In
older age, CD4 T cells lose the expression of the costimulatory receptor
CD28, hence become impaired in their ability to provide help to B cells
and stimulate effective antibody responses (Saurwein-Teissl et al.,
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CMV infection lose proliferative and antiviral activity (Appay et al.,
2002). Recent studies conﬁrm a negative correlation between CMV
titer and responses to vaccine inﬂuenza virus in older people. In partic-
ular, late differentiated CD4 T cells are associated with poorer vaccine
responses (Derhovanessian et al., 2013; Moro-Garcia et al., 2012).
CMV seropositivity can also compromise the ability of older people
to respond to simultaneous Epstein–Barr virus (Khan et al., 2004), fur-
ther demonstrating that the accumulation of CMV-speciﬁc CD8 T cells
is detrimental to responses against heterologous viruses.
On the other hand, we and others have recently described that
polyfunctionality of both CD4 and CD8 T cells elicited by CMV infection
is not affected by age (Lachmann et al., 2012; Lelic et al., 2012) so,
although memory phenotype is clearly affected by CMV infection,
functional results are controversial.
Among the most relevant antigen-speciﬁc responses, the CD4 T cell
response toMycobacterium tuberculosis (M.tb) is one of themost tested,
as the majority of people have either been exposed to M.tb or have
received Bacille Calmette–Guerin (BCG) vaccination and have a positive
reaction to tuberculin. Tuberculin puriﬁed protein derivative (PPD) is
commonly used as recall antigen for testing in vivo systemic immunity
to tuberculin in inexpensive skin tests (tuberculin test or Mantoux
test)(Huebner, 1993).
An in vitro assessment of systemic PPD and CMV responses can be
achieved by testing the IFN-γ production after antigen restimulation
of blood derived T cells. The number of IFN-γ+ T cells reactivated
in vitro with selected CMV antigens has generally been found to be
higher in older seropositive compared to younger subjects (Ouyang
et al., 2004; Vescovini et al., 2007), further suggesting that ageing is as-
sociated with a dysfunctional expansion of CMV effector responses that
reduce the available repertoire of T cells for other antigens.
IFN-γ produced by antigen-speciﬁc CD4 Th1 cells is critical for the
control of M.tb infection (Kaufmann, 2005) and several studies have
demonstrated that both recently transmitted and reactivated tuberculo-
sis rates increase with the impairment of antigen-speciﬁc CD4 T cell
responses in ageing (Cruz-Hervert et al., 2012; Friedman et al., 2008;
Horsburgh et al., 2010).
Also, just like observed in CMV (Fletcher et al., 2005), chronic M.Tb
stimulation is thought to drive M.Tb-speciﬁc CD4 T cells to end-stage
differentiation, replicative exhaustion and progressive degeneration
(Day et al., 2011; Reiley et al., 2010).
In this study, we set out to explore CMV and tuberculin-speciﬁc CD4
T-cell responses in healthy young and older people in the South of
England and questioned how responses to tuberculin may be affected
by age and CMV infection but, more importantly, by the size of the
CMV-speciﬁc immune response in older age. Interestingly in this
context, Akbar et al. (Akbar et al., 2013) previously reported that
IFN-γ responses following in vitro restimulation with tuberculin are
comparable across different age groups, and Fletcher et al. previously
demonstrated that in CMV infected (CMV+) older people, tuberculin-
speciﬁc CD4 T-cell are more differentiated (measured by the presence of
CD28−CD27− CD4 T-cells) than in CMV− older people. However, we
were interested in particular if, beyond simple CMV infection status, the
CD4 T-cell CMV-speciﬁc response size had an effect on the size and/or
functionality of tuberculin-speciﬁc CD4 T cell response.
Our results conﬁrm that in older people tuberculin-induced T-cells
show a more terminal differentiation phenotype in CMV-infected com-
pared to uninfected individuals; however, our results signiﬁcantly extend
previous ﬁndings to show that it is the actual size of the CMV-speciﬁc re-
sponse rather than its mere presence that affects both phenotype and
function of the immune response to mycobacterial antigens in older life.
2. Results
As a starting point to this investigation we observed several
extremely high tuberculin-inducible CD4 T-cell responses in healthyolder people (of the order of several percent of CD4 T-cells), which we
had never seen in young ormiddle-aged people. This raised the obvious
question whether there is an increase of tuberculin-speciﬁc T-cells in
older age with expansions similar to those seen in CMV infection. A
systematic comparison between a group of young and older individuals
originally recruited to study CMV-speciﬁc immunity revealed, however,
that while therewere indeed some extremely big responses in the older
group, therewas no signiﬁcant overall difference (mean ormedian) and
some young people had exceptionally large responses as well (Fig. 1A).
This was true when response size was based on each individual
activation marker (degranulation, CD40L upregulation, IL-2, TNF-α, or
IFN-γ production) or on all markers at the same time, i.e. counting
cells as activated if at least one of the markers is upregulated. Since
CMV infection is thought to drive inﬂammation in older life, we
wondered if there was a difference in tuberculin-speciﬁc CD4 T-cell
response sizes between infected (CMV+) and uninfected (CMV−)
individuals, across both age groups and in each group alone (Fig. 1B–
D). However, none of the differences were statistically signiﬁcant.
It was of note though that among the older people very high CMV-
speciﬁc CD4 T-cell responses (induced by stimulation with virus lysate)
occurred in the same people that displayed very large tuberculin-speciﬁc
responses. Indeed, there was a signiﬁcant albeit weak correlation
between these responses among the whole group (0.289, 0.037,
n = 49) but a much stronger correlation in the older people
(p = 0.509, p = 0.001, n = 39) (Fig. 1E). There were only ten cases
among the young with both responses, but they were not well correlat-
ed (0.055, p = 0.881, n = 10). Neither the CMV-speciﬁc (not shown)
nor the tuberculin-speciﬁc response (Fig. 1F) correlated signiﬁcantly
with age.
As CMV is known to drive the whole T-cell compartment towards a
more terminal differentiation stage (Fletcher et al., 2005), we wondered
if phenotype and functionality of the tuberculin-speciﬁc response in
older people would be affected by CMV-status, phenotype or functional
proﬁle of the CMV-speciﬁc T-cell response. When comparing CMV+ and
CMV− individuals we found that the memory phenotype distribution of
tuberculin-induced CD4 T-cells displaying degranulation, TNF-α and
IFN-γ production was more skewed towardmore differentiated memory
compartments. For all three markers, a signiﬁcantly smaller proportion
of these cells was in the TCM compartment in CMV+ compared to
CMV− people (Fig. 2); for IFN-γ and TNF-α the proportion of the
TEM compartment was signiﬁcantly larger in CMV+older people.
We next explored if the phenotype distribution of tuberculin-speciﬁc
CD4 T-cells was affected by the size of the CMV-speciﬁc CD4 T-cell
response and, for comparison, by the size of the tuberculin-speciﬁc
response. In order to do so, we selected IFN-γ and TNF-α responses to
analyze the distribution of tuberculin-speciﬁc CD4 T-cells identiﬁable by
these markers across the subsets deﬁned by CD27 and CD45RA.
These T-cell memory compartments are frequently referred to as
‘naive’ (TNAIVE = CD45RA+/CD27+), ‘central memory’ (TCM =
CD45RA−CD27+), ‘effector memory’ (TEM = CD45RA−CD27−), and
‘revertant’ (TEMRA = CD45RA+CD27−). Some authors use deﬁnitions
of these subsets based on other markers resulting in similar albeit not
identical distributions (Appay et al., 2008). Interestingly, the
tuberculin-speciﬁc TCM subset (both with respect to IFN-γ and TNF-α
responses) seemed to decrease whereas the TEM and TEMRA compart-
ments seemed to increase as a function of CMV-speciﬁc CD4 T-cell
response size. However, only the correlations between the CMV-
speciﬁc CD4 T-cell response size and tuberculin-speciﬁc IFN-γ+
producing CD4 TCM and TEMRA compartments were signiﬁcant (r =
−0.451, p = 0.004 and r = 0.336, p = 0.0346 respectively)
(Table 1). All other correlations shown in Table 1 have to be
described as non-signiﬁcant trends.
While phenotype is not necessarily correlated with T-cell effector
potential, polyfunctionality is thought to correlate with response
efﬁciency (protection) at least in some situations. In regards to tubercu-




Fig. 1. Tuberculin-speciﬁc CD4 T-cell responses by age group or CMV serostatus. Tuberculin-speciﬁc CD4 T-cells were analyzed by ﬂow-cytometry in young and older individuals after ex-
vivo antigen stimulation. Activated T cells were identiﬁed by intracellular cytokine staining. Whereas young donors had marginally higher median responses to tuberculin than older
people (A), there were no signiﬁcant differences in regards to CMV serostatus, neither in the whole group (B), nor in the older (C) and young (D) subgroups, indicating that neither
age nor CMV-infection increases immunity to mycobacterial antigen.However, the size of the CMV-speciﬁc CD4 T-cell response had a positive effect on the size of the tuberculin-speciﬁc
CD4 T-cell response (E). No such effect was seen with age (F).
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subsets are more frequently found in individuals who control TB
infection.
Subsets with exactly one, two, three, four, or, ﬁve parallel ‘functions’,
where ‘function’ refers to each tested activationmarkers (IFN-γ, TNF-α,
IL2, as well as degranulation and CD154 upregulation) are non-
overlapping and can be expressed as percentage of all CD4 T-cells.
This is a somewhat crude approach but has been useful when analyz-
ing polyfunctionality of CMV-speciﬁc T-cell responses in the past
(Lachmann et al., 2012). Fig. 3A shows that there was no signiﬁcant
difference between CMV+ and CMV− individuals in regards to these
subsets. However, when plotted against the size of the CMV-speciﬁc
CD4 T-cell response, it became obvious that all of these functional
subsets tend to increase as a function of the size of that response
(Fig. 3B). They correlated even better with the size of the tuberculin-
speciﬁc CD4 T-cell response (Fig. 3C), but not with age (Fig. 3D).
In order to understand if more subtle functional changes were
associated with CMV serostatus, we ﬁnally analyzed the distribution of
31 non-overlapping Boolean subsets deﬁned by the 5 activation
markers (Lachmann et al., 2012; Roederer et al., 2011). Not all subsets
were detected in all participants but some were clearly very dominant.The most dominant subset displayed only one of the tested functions,
CD154+, followed by the subset displaying only CD154+ and TNF-α +.
The third most dominant subset displayed CD154+, IL-2+, and TNF-α +
but no other functions. These dominant subsets did not discriminate be-
tweenCMV+andCMV− individuals. However, four subsets seemed todi-
vide the two groupswith a p-value below 0.05; they had in common that
they were IFN-γ+/TNF-α+/IL-2−. However, since this was a comparison
with 31 statistical endpoints, the signiﬁcance level dropped to
p = 0.05/31 = 0.0016 by way of Bonferoni multiple end-point correc-
tion. Two subsets still remained signiﬁcantly different between the
groups; they were both CD154− (Fig. 4). This reﬂected the phenotype
analysis (Fig. 2) showing that tuberculin-speciﬁc CD4 T-cells displaying
IL-2 or CD154 upregulation had no signiﬁcantly different memory subset
distribution in CMV+ and CMV− individuals.
3. Discussion
Tuberculin-inducible T-cell responses in the skin result from TB
infection, exposure, or vaccination and are often used to assess T-cell
immunity to M. tuberculosis. We and others have previously shown
that such responses can also be effectively tested using in vitro activation
γα
Fig. 2. Tuberculin-induced CD4 T-cells in older individuals display a more advanced differentiation phenotype in the presence than in the absence of CMV infection. The phenotypic dis-
tribution of tuberculin-induced CD4 T-cells in older donorswas analyzed by ﬂow cytometry. Pies were normalized to represent the proportion of each of fourmemory subsets in terms of
thewhole response deﬁned by the selected functions. Pie charts in each row allow comparison of the effect of CMV infection. It is obvious that in CMV+ individuals, effector functions such
as degranulation, IFN-γ or TNF-α production originate fromcells that are on averagemore terminally differentiated than in CMV− individuals. Because the functions overlap, a comparison
between pie charts within the same columns is not useful.
Table 1
Correlations between the phenotypic distribution of IFN-γ+ or TNF-α+ tuberculin-speciﬁc CD4 T-cells and the size of the CMV-speciﬁc CD4 T cells.
TNF-α IFN-γ
TNAIVE TCM TEM TEMRA TNAIVE TCM TEM TEMRA
Age Pearson correlation 0.149 0.076 −0.147 −0.016 0.219 0.140 −0.187 −0.080
Signiﬁcance (2-tailed) 0.366 0.644 0.371 0.924 0.179 0.394 0.255 0.629
N 39 39 39 39 39 39 39 39
CD4 CMV (log) Pearson correlation −0.064 −0.297 0.236 0.222 0.098 −0.451⁎⁎ 0.226 0.336⁎
Signiﬁcance (2-tailed) 0.699 0.066 0.147 0.175 0.553 0.004 0.166 0.0364
N 39 39 39 39 39 39 39 39
⁎⁎ Correlation is signiﬁcant at the 0.01 level (2-tailed).
⁎ Correlation is signiﬁcant at the 0.05 level (2-tailed).
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Fig. 3. Polyfunctionality of tuberculin-speciﬁc CD4 T-cell subsets correlates with the size of CMV and tuberculin-speciﬁc CD4 T-cell response but not age. Older donors were analyzed by
ﬂow cytometry for polyfunctional responses following ex-vivo stimulation with tuberculin or CMV lysate. Polyfunctionality was deﬁned as the parallel presence of several activation
markers in antigen activated T-cells. CD154+/TNF-α+/IFN-γ+/IL-2+/degranulation+ CD4 T-cells were the most polyfunctional cells in the study and correspond to cells with 5 parallel
functions in the diagrams. Rather than displaying 31 functional subsets, cells were grouped by the number of parallel functions from 1 to 5. There is no signiﬁcant difference of
tuberculin-speciﬁc CD4 T-cell responses between CMV− and CMV+ individuals grouped by the number of parallel functions (A). Therewere signiﬁcant correlations between the percent-
age of subsets with 2, 3, and 4 parallel functions and both the sizes of the CMV and tuberculin-speciﬁc CD4 T-cell responses (B and C respectively) but not age (D). The Pearson correlation
coefﬁcient (r) and corresponding p-values for signiﬁcant associations are indicated.
Fig. 4. Individual functional subsets of tuberculin-induced CD4 T-cells differentiate be-
tween CMV+ and CMV− individuals. Older donors were analyzed by ﬂow cytometry for
tuberculin-speciﬁc CD4 T-cell responses following in vitro antigen stimulation. Activated
T cells were identiﬁed by intracellular cytokine staining. Based on 5 individual functions,
IFN-γ, TNF-α, IL2 production, as well as degranulation and CD154 upregulation, 31 non-
overlapping functional Boolean subsets were generated. Of these, 4 were signiﬁcantly
different in CMV+ and CMV− individuals given a signiﬁcance level of p = 0.05. However,
following multiple end-point correction (Bonferoni) differences with respect to only 2
subsets remained signiﬁcant. These were IFN-γ+, TNF-α + but IL-2− and CD154−, with
or without degranulation. This indicates that being CMV-positive selectively increases
some terminally differentiated effector subsets.
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et al., 2007; Tesfa et al., 2004). In the present study this response was
analyzed in parallel to the CMV-speciﬁc response in 80 healthy individ-
uals. In keeping with reports by others, systematic data analysis did
not conﬁrm our initial observation that older people have higher
tuberculin-speciﬁc T-cell responses than younger people (Akbar et al.,
2013). Interestingly though comparisons between different age groups
in regards to CD4 T-cell responses to CMV-antigens have provided equiv-
ocal data (Fletcher et al., 2005; Lachmann et al., 2012; Ouyang et al., 2004;
Wills et al., 2011). In the present study, no correlation between age and
the size of the CMV-speciﬁc CD4 T-cell response was seen. It is likely
that the size of the CMV-speciﬁc T-cell response (and probably responses
to other infectious antigens as well) is related to the time since ﬁrst
exposure or duration of infection and there is general agreement that
chronological age is only a weak correlate of the former (Lachmann
et al., 2012). As a result, different studies might ﬁnd different results
depending on the background of the population studied, in particular
the percentage of CMV-infected people at a younger age. None of the
donors recruited in this study had a known history of TB infection and,
for most, their TB exposure would have resulted from a combination of
vaccination and exposure to active TB cases, which would have provided
a booster to the vaccination response. It is not possible to speculate how
the way of exposure would have affected the response in any speciﬁc
case.
It was striking, however, that the largest tuberculin-speciﬁc re-
sponses were found in the same people who had the largest CMV-
speciﬁc responses. This is the ﬁrst report to show that these responses
are highly correlated in older people, but less so in younger people
(where not many individuals displayed both responses, possibly due
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infected and uninfected people in regards to general lymphocyte
compartment composition (Chidrawar et al., 2009) suggest that CMV
infection is indeed a driver of profound immune system changes
(which does not rule out that there may be other such drivers in
CMV-uninfected people as well). In extension of these results, the
sizes of CMV-speciﬁc CD8 and CD4 T-cell responses have previously
been shown to quantitatively correlate with the distribution of the
CMV-speciﬁc and also the whole T-cell compartment into memory T-
cell subsets deﬁned by the expression of CD27 and CD45RA. Larger
CMV-speciﬁc responses go together with a more terminal differentia-
tion phenotype of all T-cells (fewer naive and more cells of advanced
differentiation phenotype, particularly in central and effector memory
compartments) (Lachmann et al., 2012). This truly important observa-
tion suggests that comparisons of inﬂammatory parameters across
groups deﬁned by CMV serostatus alone often give less clear results.
The huge variability of the T-cell response size in CMV-infected individ-
uals is simply not well reﬂected by a positive or negative CMV infection
status. A correlation between CMV-antibody levels (OD-values) and the
size of the T-cell response has not been reported in the literature and
was not seen in the present study either (not shown). As a result,
CMV-serostatus or antibody levels do not reﬂect very well what we
would like to call the CMV-related immune ‘response mode’.
While no strict correlations exist between T-cell subset phenotype
and function, there is good evidence that the most polyfunctional
CMV-speciﬁc T-cell subsets are in the TCM compartment, whereas
subsets producing IL-2 are more likely to be in the TNAIVE compartment
(Lachmann et al., 2012). Subsets focused on just one or two functions, in
particular effector functions such as degranulation, TNF-α, or IFN-γ
production aremore likely to be found in TEM and TEMRA compartments.
Our analysis of the present study indicates that tuberculin-speciﬁc
CD4 T-cells that are degranulating and producing TNF-α or IFN-γ
are more differentiated in the presence than in the absence of CMV
infection and that certain functional subsets displaying effectormarkers
(degranulation, TNF-α, IFN-γ) but not IL-2 or CD40L are signiﬁcantly
increased in CMV-infected older people. These subsets are quite small
in absolute terms; however, their difference illustrates the polarizing
effect of CMV on T-cell immunity more generally. The fact that these
differences were observed when comparing groups simply by CMV
serostatus, in light of the discussion above, suggests that these are
strong effects; it is important to note, though, that the degree of pheno-
type skewing is a function of response size, suggested by the present
data and as previously shown (Lachmann et al., 2012). Larger responses
are thus more likely to affect the T-cell response to other pathogens
through a bystander effect that yet needs to be deﬁned but may be
related to cytokine production.
In summary, we conclude that the size of the CMV-speciﬁc T-cell
response is probably an indicator of a T-cell ‘responsemode’ that is likely
to be related to ‘inﬂammaging’ and potentially survival at older age
(Derhovanessian et al., 2009). That CMV-speciﬁc responses grow bigger
in some people than others is likely a multifactorial effect including
disposition as well as environmental factors. Whether the changes of
the tuberculin-speciﬁc response seen in the face of large CMV-speciﬁc
responses positively or negatively affect immunity to mycobacterial
antigens such as, for example, the response to reactivation in latently
tuberculosis-infected people is not known but will be worth looking
into.
Finally, we believe that CMV-speciﬁc response size should also be
considered in studies examining the effect of CMV carriage on the
results of inﬂuenza vaccination (den Elzen et al., 2011). A recent
study (Derhovanessian et al., 2013) has shown that , among CMV-
seropositives, a poorer vaccine takewas associatedwithmore advanced
differentiation of CD4 T-cells in peripheral blood, which, according to
previously published data (Almanzar et al., 2005; Chidrawar et al.,
2009; Derhovanessian et al., 2011; Looney et al., 1999), would reﬂect
a larger CMV-speciﬁc CD4 T-cell response.4. Materials and methods
4.1. Donors
Blood was taken from 131 healthy older volunteers (60 to 85 years
old) recruited from general practices and from 55 young people (20 to
35 years old) recruited from university students/staff (over 90% were
white Caucasian, the remainder black African or Asian). The protocol
was approved by the UK National Research Ethics Service (NRES) and
appropriate written informed consent was obtained. Routine serology
(CMV-IgG) was obtained from the Brighton and Sussex University
Hospital (BSUH) virology laboratory. Tuberculin-speciﬁc CD4 T-cells
were above detection threshold (deﬁned as 1/10,000) in 103 partici-
pants, of whom 62 were CMV+ (including n = 10 young and n = 31
older people) and 42 were CMV− (including n = 13 young and
n = 41 older people). ‘Young’ people were between 20 and 35 years
old; older people were 60–85 years old.
Exclusion criteria included immunodeﬁciency (including HIV-
infection), organ transplantation, use of immunosuppressive/
immunomodulating drugs within the last year, cancer or cancer
treatment within the last 5 years, insulin dependent diabetes,
moderate/advanced renal failure, liver disease, endocrine disorders
(other than corrected thyroid dysfunction), autoimmune disease,
dementia/mental incompetence (MMSE b28), alcohol/other drug
abuse, acute infection/illness in the last 4 weeks, and raised body tem-
perature. Among older participants, 42% were taking antihypertensive
drugs and/or beta blockers; 14% were taking cholesterol-lowering
drugs).
4.2. Reagents
SEB (Source, Town, Country) and PPD (Puriﬁed Protein Derivative
‘human tuberculin’ SSI, Copenhagen, Denmark proteins) were used in
PBMC assays at a ﬁnal concentration of 5 μg/ml and 10 μg/ml respec-
tively. Custom peptide-pools (“PepMix”, JPT Peptide Technologies,
Berlin) for each CMV protein (Table 1) were dissolved in DMSO
(Sigma-Aldrich), aliquoted for short-term storage at−20 °C and used
in stimulations at a ﬁnal concentration of 1 μg/ml per peptide for each
pool.
4.3. PBMC activation assays
Peripheral blood mononuclear cells (PBMCs) were isolated from
heparin blood by density gradient centrifugation (Ficoll-Hypaque,
PLUS Healthcare, Buckinghamshire, UK). PBMCs were washed twice
with PBS, resuspended in complete media and stimulated in sterile
polystyrene round bottom tubes (Falcon; BD Biosciences). Each tube
contained 106 PBMC, anti-CD107a antibody (BD Biosciences),Monensin
(‘Golgistop’, BD Biosciences), one of the stimulants (SEB, one of 16
different PepMix solutions, or tuberculin) plus complete media to a
ﬁnal volume of 250 μl. Stimulations were incubated at 37 °C in 5%
CO2, humidiﬁed atmosphere, for 2 h prior to the addition of 250 μl
Brefeldin A (BFA, ﬁnal concentration 10 μg/ml; Sigma-Aldrich). Incuba-
tion was stopped after an additional 14 h.
4.4. Flow cytometry
After 14 h of incubation, 100 μl 20 mM EDTA was added to each
tube and incubation continued for 10 min at 37 °C. Cells were then
washed with FACS buffer and stained with v500-conjugated anti-CD3,
APC-H7-conjugated anti-CD8, PE-conjugated anti-CD27 (BD Biosci-
ences), peridinin–chlorophyll–protein complex (PerCp)-conjugated
anti-CD4 (BioLegend), ECD-conjugated anti-CD45RA (Beckman Coulter,
High Wycombe, UK), and live/dead yellow stain (Invitrogen). After
30 min incubation at 4 °C, cells were treated with BD FACS lysing solu-
tion andBDFACS permeabilizing Solution II according tomanufacturer's
100 N. Terrazzini et al. / Experimental Gerontology 54 (2014) 94–100instructions (BD Biosciences). For intracellular cytokine staining,
the following antibodies were used: Paciﬁc Blue (PB)-conjugated
anti-CD154, PE-Cy7-conjugated anti-IFN-γ (BioLegend), Alexa 700-
conjugated anti-TNF-α, and FITC-conjugated anti-IL-2 (BD Biosci-
ences). After 30 min incubation at 4 °C, cells were washed, ﬁxed
with 0.5% PFA for 5 min, RT, then washed again and kept at 4 °C in
the dark until acquisition. Cells were analyzed on an LSRII ﬂow
cytometer using FACSDiva-v6.1 software (BD Biosciences) and
analyzed using FlowJo-v9 software (TreeStar Inc., Ashland, USA). In
order to identify functional combinations of markers, Boolean gates
were used on separate gates set for each activation marker on CD4
and CD8 T-cells (IL-2, degranulation, CD154, TNF-α, and IFN-γ). In
this study ‘activated’ effector T-cells are represented by the percent-
age of cells displaying at least one of the markers in the sum of all
Boolean gates. For each individual gate, values for unstimulated sam-
ples (negative control) were subtracted from those for stimulated
samples.
4.5. Statistical analysis
Statistical tests were performed with SPSS-20. A two-sided p b 0.05
was considered statistically signiﬁcant, unless multiple end-point
correction (Bonferoni) was performed as indicated.
For the calculation of Pearson correlation coefﬁcients (SPSS bivariate
correlation procedure) log-transformed T-cell subset percentages were
used. Log transformation of T-cell subset percentages improved the
normality of distributions.
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